AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · IEX Real-Time Price · USD
23.94
-0.67 (-2.72%)
At close: Jul 2, 2024, 4:00 PM
24.89
+0.95 (3.97%)
After-hours: Jul 2, 2024, 7:19 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $654.01 million as of July 2, 2024. Its market cap has increased by 21.99% in one year.
Market Cap
654.01M
Enterprise Value
316.73M
1-Year Change
21.99%
Ranking
Category
Stock Price
$23.94
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $654.01M, an increase of 111.86%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 672.30M | 18.11% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 704.15M |
| ProKidney | 702.14M |
| The Pennant Group | 696.76M |
| UroGen Pharma | 690.16M |
| OrthoPediatrics | 685.32M |
| GeneDx Holdings | 683.58M |
| Evolus | 679.32M |
| Phibro Animal Health | 679.25M |